Renal denervation using an irrigated catheter in patients with resistant hypertension: A promising strategy?;Denervação renal com cateter irrigado em hipertensos resistentes: Uma estratégia promissora?

Arquivos Brasileiros de Cardiologia

Volumn 102, Issue 4, 2014, Pages 355-363

  Armaganijan, Luciana ^a   Staico, Rodolfo ^a   Moraes, Aline ^a   Abizaid, Alexandre ^a   Moreira, Dalmo ^a   Amodeo, Celso ^a   Sousa, Márcio ^a   Borelli, Flávio ^a   Armaganijan, Dikran ^a   Eduardo Sousa, J ^a   Sousa, Amanda ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Catheter ablation; Hypertension; Inimally invasive; Kidney innervation; Surgical procedures; Sympatectomy Methods

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCERYL TRINITRATE; HEPARIN;

ABLATION CATHETER; ADULT; ANTICOAGULATION; ARTERIOGRAPHY; ARTICLE; CATHETER; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DEVICE SAFETY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY ARTERIOGRAPHY; KIDNEY DENERVATION; KIDNEY FUNCTION; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PUBLIC HEALTH PROBLEM; RENAL ARTERY ANEURYSM; RESISTANT HYPERTENSION;

ADULT; ANGIOGRAPHY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CATHETER ABLATION; CREATININE; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; REPRODUCIBILITY OF RESULTS; SYMPATHECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899714812     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20140034     Document Type: Article

References (9)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
2. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076-80.
3. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356(9246):1955-64.
4. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510-26.
5. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903-9.
6. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. VI Diretrizes brasileiras de hipertensão. Arq Bras Cardiol. 2010;95(1 supl.1):1-51.
7. Krum H, Barman N, Schlaich M, Sobotka P, Esler M, Mahfoud F, et al; Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-7.
8. Staico R, Armaganijan L, Dietrich C, Abizaid A, Moreira D, Lopes R, et al. Ablação da atividade simpática renal com cateter de ponta irrigada: uma opção atraente? Rev Bras Cardiol Invasiva. 2013;21(1):7-12.
9. Ahmed H, Neuzil P, Skoda J, Petru J, Sediva L, Schejbalova M, et al. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc Interv. 2012;5(7):758-65.